Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Advanced Solid Tumor 13Leukemia, Myeloid, Acute 10Carcinoma, Non-Small-Cell Lung 7Advanced Solid Tumors 7Breast Neoplasms 6Solid Tumor 5Pancreatic Neoplasms 5Melanoma 5Triple Negative Breast Neoplasms 4Ovarian Neoplasms 4Neoplasms 4Neoplasm Metastasis 4Lymphoma, Non-Hodgkin 4Solid Tumors 3Recurrence 3Myelodysplastic Syndromes 3Lung Neoplasms 3Leukemia, Biphenotypic, Acute 3Esophageal Neoplasms 3Carcinoma, Hepatocellular 3Biliary Tract Neoplasms 3Advanced Malignant Solid Tumor 3Advanced Lung Cancer 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Prostatic Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2

Interventions

Peripheral Blood Stem Cell Transplantation 11Mycophenolic Acid 8Cyclosporine 8fludarabine phosphate 7Imatinib Mesylate 6Busulfan 5Tacrolimus 4Radiotherapy 4Methotrexate 4Cyclophosphamide 4nilotinib 3bosutinib 3Whole-Body Irradiation 3Cord Blood Stem Cell Transplantation 3Antilymphocyte Serum 3Melphalan 2Filgrastim 2Dasatinib 2Cytarabine 2Alemtuzumab 2sargramostim 1ruxolitinib 1ponatinib 1montanide ISA 51 1liposomal doxorubicin 1ethanolamine oleate 1avelumab 1atezolizumab 1aldesleukin 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Leukemia, Myeloid, Chronic-Phase × Injections × Clear all
NCT04793399 2024-03-19

Safety and Efficacy Evaluation of Bosutinib Plus Atezolizumab in Newly Diagnosed Chronic Leukemia Adult Patients

Fundacion Espanola para la Curacion de la Leucemia Mieloide Cronica

Phase 1/2 Terminated
9 enrolled 7 charts
Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡